Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial
Resource Type
Article
Authors
Holmes, Frankie A. ; Moy, Beverly ; Delaloge, Suzette ; Chia, Stephen K.L. ; Ejlertsen, Bent ; Mansi, Janine ; Iwata, Hiroji ; Gnant, Michael ; Buyse, Marc ; Barrios, Carlos H. ; Silovski, Tajana ; Šeparović, Robert ; Bashford, Anna ; Zotano, Angel Guerrero ; Denduluri, Neelima ; Patt, Debra ; Gokmen, Erhan ; Gore, Ira ; Smith, John W., II ; Loibl, Sibylle ; Masuda, Norikazu ; Tomašević, Zorica ; Petráková, Katarina ; DiPrimeo, Daniel ; Wong, Alvin ; Martin, Miguel ; Chan, Arlene
Source
In European Journal of Cancer May 2023 184:48-59
Subject
Language
ISSN
0959-8049